Trade Symposia
- Thursday 14 May 2026
- 07:00 - 07:50
- Beyond the first botulinum toxin injection: The Importance of an “Individualized” treatment plan for patients with spasticity
- Prof Andre Mochan (SA)

Prof Andre Mochan
Prof Andre Hans Dieter Mochan is a senior neurologist and academic leader who qualified in medicine in 1993 and obtained his specialist neurology fellowship in 1998. With close to three decades of clinical experience in neurology, he serves as Head of Clinical Unit, Neurology at Chris Hani Baragwanath Academic Hospital and Academic Head of Neurology at the University of the Witwatersrand. His areas of expertise include HIV neurology, stroke, motor neuron disease, neurophysiology, neuro-immunology, movement disorders and spasticity management. Over the years, he has made a substantial contribution to specialist patient care, service development, teaching and research, including establishing the multidisciplinary motor neuron disease clinic, leading botulinum toxin services for dystonia and spasticity, supervising postgraduate trainees, and helping shape national specialist training and assessment in neurology. His work in patient care was recognized with a 2018 Centre for Public Service Innovation Award, and he currently serves as President of the College of Neurologists of South Africa.
- Thursday 14 May 2026
- 08:00 - 08:50
- The Paradigm Shift in MS Management – focusing on real world evidence and the benefits of early initiation of HET.
- Prof Anneke van der Walt (AUS)
- Thursday 14 May 2026
- 18:30 - 20:30
- Navigating MS Treatment Transitions: Best Practices for MAVENCLAD
- Dr Jiwon Oh (CAN)
- Friday 15 May 2026
- 07:00 - 07:50
- Empowering Choices: Optimizing Maternal and Neonatal Outcomes in the Era of High-Efficacy MS Therapy.
- Prof Riley Bove (SA)

Prof Riley Bove
Dr. Bove is a national and international leader in sex and gender aspects of Neurology, publishing, collaborating and lecturing widely on this topic. She is PI of the first industry-sponsored Phase IV trial of a medication for use in pregnant and lactating people with MS and led the first RCT in menopausal women with MS. She is founding Director of the SAGE (Sex and Gender Enriched) Neurology Program at UCSF, which provides specialized clinical care, education, and research focused on sex- and gender-informed neurology In the technology space, Dr. Bove has conducted innovative work designing, validating and implementing digital tools to improve care access, holistic measures of patient function, and as digital therapeutics. She is co-PI of the BRIDGE precision medicine dashboards that support delivery of point-of-care personalized medicine. Dr. Bove graduated Phi Beta Kappa in anthropology from Harvard College. She received her MD and MMSc from Harvard Medical School. She completed a neurology residency in the Massachusetts General/Brigham Hospitals program, followed by a clinical research fellowship at the Partners MS Center. Dr. Bove serves on the Science Committee of the American Academy of Neurology and is on the Editorial Board of Annals of Neurology and Neurology N2. She is committed to training the next generation of clinicians and scientists, and mentors students, doctoral and postdoctoral trainees in a variety of individualized clinical and training plans. Dr. Bove contributes to global neurology and equity initiatives through the Global Teleneurology Service and the BALANCE program.
- Friday 15 May 2026
- 08:00 - 08:50
- New Era for NMOSD. "Complementopathy" and "Precision Medicine"
- Prof Jin Nakahara (JPN) - Virtual

Prof Jin Nakahara
Jin Nakahara is based in Tokyo, Japan as a Professor and Chair of the Department of Neurology at Keio University School of Medicine. He is also a Director of iPS Cell Research Center for Intractable Neurological Disorders at Keio University (KiND). He is appointed as Visiting Professor at Kanazawa University Graduate School of Medical Sciences and The Jikei University School of Medicine. Professor Nakahara received his M.D. from Keio University School of Medicine in 2003 and his Ph.D. from Keio University Graduate School of Medicine in 2007. More than 160 articles in the field of neurology, neuroscience, and neuroimmunology have been published in leading international journals, such as Journal of Neuroscience, Neurology, Brain, Annals of Neurology, Journal of Clinical Investigation, Cell Stem Cell, JAMA Neurology, Science Immunology, and Nature Neuroscience. He holds active memberships with many professional societies in Japan and abroad, and he is currently a Director of the Japanese Society of Neuroimmunology and the Japanese Society for Microcirculation. He also serves as an Executive Committee Member of Pan-Asian Congress for Treatment and Research in Multiple Sclerosis (PACTRIMS).
- Saturday 16 May 2026
- 08:00 - 08:40
- On the Horizon: The Next Generation of Migraine Therapy in South Africa
- Dr Shaheed Gora (SA)
- Saturday 16 May 2026
- 08:45 - 09:25
- An Update on Insomnia
- Dr Raksha Sitharam (SA)